STUDIES OF RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY
肝性脑病发病机制的相关研究
基本信息
- 批准号:3918247
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:GABA receptor acute disease /disorder aminoacid inhibitor benzodiazepine receptor benzodiazepines bicuculline brain metabolism disease /disorder model drug interactions evoked potentials gamma aminobutyrate heart Purkinje's fiber hepatic coma /encephalopathy hepatotoxin human subject human tissue laboratory rabbit liver disorder chemotherapy liver failure liver metabolism membrane permeability neuropharmacology neurotoxins
项目摘要
The abnormal pattern of visual evoked responses (VERs) in animals
with hepatic encephalopathy (HE) due to fulminant hepatic failure
(FHF) resembles that associated with encephalopathy induced by
drugs which promote GABA-ergic neurotransmission, including
benzodiazepines (BZs). These findings suggest that the pattern of
neuronal activity in HE may resemble that associated with
activation of the GABA inhibitory neurotransmitter system.
Furthermore, rabbits with HE due to FHF exhibit increased
resistance to the convulsive effects of the GABA receptor
antagonist, bicuculline. Ameliorations of HE (both clinical and
electrophysiologic (VER waveform)) have been induced in animals
with FHF by BZ receptor antagonists. Furthermore, spontaneous in
vitro activity of Purkinje neurons from rabbits in HE due to FHF
exhibited increased sensitivity to depression by agonists of the
GABA/BZ receptor complex, including a BZ, and, in contrast to
control neurons, exhibited excitation when exposed to BZ receptor
antagonists. These findings suggest that in HE due to FHF: (i)
There is increased GABA-ergic tone; (ii) Blockading of BZ receptors
can ameliorate HE; (iii) BZ receptor antagonists may be of value
in the management of HE; and (iv) An endogenous BZ receptor agonist
may contribute to HE. Such a ligand is being isolated from
supernatants of brain obtained from models of HE.
动物视觉诱发反应的异常模式
暴发性肝衰竭所致的肝性脑病
(FHF)类似于由以下因素引起的脑病
促进GABA能神经传递的药物,包括
苯二氮卓类(BZS)。这些发现表明,
HE患者的神经元活动可能类似于
激活GABA抑制性神经递质系统。
此外,由于FHF导致的HE兔表现出增加
对GABA受体惊厥效应的抵抗
拮抗剂荷包牡丹碱。对HE的改善(包括临床和
电生理(VER波形)已在动物中诱导
用BZ受体拮抗剂治疗FHF。此外,自发进入
家兔浦肯野神经元对FHF致HE的体外活性
通过激动剂表现出对抑郁的更高敏感性
GABA/BZ受体复合体,包括BZ,与
对照神经元在暴露于BZ受体时表现出兴奋
对抗者。这些发现提示FHF所致的HE:(I)
GABA能神经递质增加;(Ii)阻断BZ受体
可以改善HE;(Iii)BZ受体拮抗剂可能有价值
(Iv)内源性BZ受体激动剂
可能会对他有所贡献。这样一种配体正被从
取HE模型脑组织上清液。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E ANTHONY JONES其他文献
E ANTHONY JONES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E ANTHONY JONES', 18)}}的其他基金
STUDIES OF ALPHA-1-ANTITRYPSIN PHENOTYPES AND METABOLISM
ALPHA-1-抗胰蛋白酶表型和代谢的研究
- 批准号:
3941102 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY & HEPATIC FAILURE
肝性脑病发病机制的相关研究
- 批准号:
3840476 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




